Altimmune, Inc. (ALT)
2.735
-0.02
(-0.91%)
USD |
NASDAQ |
Oct 02, 16:00
2.75
+0.02
(+0.55%)
After-Hours: 20:00
Altimmune Price : 2.735 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 2.80 | 2.81 | 2.71 | 2.735 | 4.253M |
| Oct 01, 2026 | 2.85 | 2.85 | 2.75 | 2.76 | 3.594M |
| Sep 30, 2026 | 2.99 | 2.99 | 2.86 | 2.86 | 4.922M |
| Sep 29, 2026 | 2.99 | 3.006 | 2.92 | 2.97 | 2.564M |
| Sep 28, 2026 | 3.04 | 3.07 | 2.95 | 2.96 | 3.360M |
| Sep 25, 2026 | 3.05 | 3.11 | 3.00 | 3.06 | 2.859M |
| Sep 24, 2026 | 3.18 | 3.20 | 2.98 | 3.04 | 3.686M |
| Sep 23, 2026 | 3.42 | 3.425 | 3.15 | 3.19 | 4.532M |
| Sep 22, 2026 | 3.33 | 3.41 | 3.25 | 3.41 | 4.003M |
| Sep 21, 2026 | 3.31 | 3.340 | 3.24 | 3.27 | 3.523M |
| Sep 18, 2026 | 3.23 | 3.26 | 3.18 | 3.25 | 12.18M |
| Sep 17, 2026 | 3.31 | 3.35 | 3.21 | 3.24 | 3.457M |
| Sep 16, 2026 | 3.27 | 3.29 | 3.195 | 3.24 | 3.332M |
| Sep 15, 2026 | 3.30 | 3.31 | 3.21 | 3.23 | 2.339M |
| Sep 14, 2026 | 3.27 | 3.36 | 3.27 | 3.30 | 2.466M |
| Sep 11, 2026 | 3.33 | 3.41 | 3.26 | 3.27 | 2.705M |
| Sep 10, 2026 | 3.32 | 3.345 | 3.25 | 3.29 | 2.563M |
| Sep 09, 2026 | 3.35 | 3.425 | 3.291 | 3.35 | 3.076M |
| Sep 08, 2026 | 3.46 | 3.550 | 3.34 | 3.36 | 3.592M |
| Sep 04, 2026 | 3.28 | 3.43 | 3.25 | 3.42 | 4.872M |
| Sep 03, 2026 | 3.30 | 3.32 | 3.19 | 3.23 | 2.552M |
| Sep 02, 2026 | 3.10 | 3.34 | 3.10 | 3.28 | 7.472M |
| Sep 01, 2026 | 3.07 | 3.095 | 3.02 | 3.09 | 2.355M |
| Aug 31, 2026 | 3.08 | 3.135 | 3.06 | 3.11 | 2.216M |
| Aug 28, 2026 | 3.21 | 3.23 | 3.06 | 3.11 | 3.194M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Protalix Biotherapeutics, Inc. | 2.71 |
| Taysha Gene Therapies, Inc. | 4.63 |
| Humacyte, Inc. | 0.5215 |
| Liquidia Corp. | 28.64 |
| Agenus, Inc. | 8.36 |
Price Related Metrics
| PS Ratio | 11026.83 |
| Price to Book Value | 1.122 |
| Earnings Yield | -28.84% |
| Market Cap | 531.89M |